http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JO-3709-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ff548dae58eeb810250f8b205c20e20
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y404-01011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y305-01001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
filingDate 2016-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e0eae7931af939ef21768ab1660782d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05424d6930d21483d2219714b0784d85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fbdb29b2f057d280d52155ba06d3c04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eec9f02b80dea1b1c1dc24f3792c726
publicationDate 2021-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JO-3709-B1
titleOfInvention A pharmaceutical or combination medicinal formulation for use in the treatment of cancer in a mammal that includes asparaginase and methionase
abstract The invention relates to a novel method for treating liquid and solid carcinomas in a mammal, including human, in which methionase is administered before asparaginase. The invention also includes the use of dietary deprivation of methionine, possibly in combination with administration of methionine, prior to asparaginase treatment. Methionase and asparaginase in particular can be used in free form, bound form, or encapsulated in erythrocytes. shape 1
priorityDate 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ73KL7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID767799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6137
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7CRG0
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537510
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41713869
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246266
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8RDT4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374569
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID104816
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8L0X4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A0J6G7P5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ826W3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID66674338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7MX71
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13254

Total number of triples: 47.